Elevation of pro-inflammatory cytokine levels following anti-resorptive drug treatment is required for osteonecrosis development in infectious osteomyelitis
Mayu Morita(Keio University), Takeshi Miyamoto(Kumamoto Health Science University), Ryuichi Watanabe(Keio University), Ken Ishii(International University of Health and Welfare), Masaya Nakamura(Keio University), Taneaki Nakagawa(Keio University), Yosuke Keneko(Keio University), Hiromasa Kawana, Kazuyuki Ishihara(Tokyo Dental College), Tami Kobayashi(Keio University), Takatsugu Oike(Keio University), Yoichiro Iwakura(Tokyo University of Science), Morio Matsumoto(Keio University Hospital), Satoshi Nakamura(Mitsubishi Research Institute (Japan)), Ryotaro Iwasaki(Keio University), Yuiko Sato(Keio University), Kana Miyamoto(Kumamoto University)
Cited by 56
Related Papers
DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells
|The Journal of Experimental Medicine|2005|899
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis
|Cell Metabolism|2006|771
Commitment and Differentiation of Osteoclast Precursor Cells by the Sequential Expression of C-Fms and Receptor Activator of Nuclear Factor κb (Rank) Receptors
|The Journal of Experimental Medicine|1999|694